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ARTICLE
Nuclear numbers in syncytial muscle fibers
promote size but limit the development of
larger myonuclear domains
Alyssa A. W. Cramer 1, Vikram Prasad1, Einar Eftestøl 1,2, Taejeong Song3, Kenth-Arne Hansson2,4,
Hannah F. Dugdale5, Sakthivel Sadayappan 3, Julien Ochala 5,6,7, Kristian Gundersen2 &
Douglas P. Millay 1,8✉
Mammalian cells exhibit remarkable diversity in cell size, but the factors that regulate
establishment and maintenance of these sizes remain poorly understood. This is especially
true for skeletal muscle, comprised of syncytial myofibers that each accrue hundreds of
nuclei during development. Here, we directly explore the assumed causal relationship
between multinucleation and establishment of normal size through titration of myonuclear
numbers during mouse neonatal development. Three independent mouse models, where
myonuclear numbers were reduced by 75, 55, or 25%, led to the discovery that myonuclei
possess a reserve capacity to support larger functional cytoplasmic volumes in developing
myofibers. Surprisingly, the results revealed an inverse relationship between nuclei numbers
and reserve capacity. We propose that as myonuclear numbers increase, the range of
transcriptional return on a per nuclear basis in myofibers diminishes, which accounts for both
the absolute reliance developing myofibers have on nuclear accrual to establish size, and the
limits of adaptability in adult skeletal muscle.
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The control of cell size is an evolutionarily conserved, funda-mental aspect of development that must be highly regulated1.Cell size varies widely based on the type of cell and overall
function, which involves a balance between available DNA and
maintenance of biosynthetic processes for optimal structure and
function2,3. Control of size in large cells, such as neurons and skeletal
muscle fibers, requires unique adaptations to reach sufficient levels of
transcripts and proteins throughout the large cytoplasm. These large
cells are maintained in different ways, where neurons actively regulate
transport of macromolecules produced in the cell body to the ter-
mini, while skeletal myofibers contain multiple nuclei dispersed
throughout one cell4,5. A classic explanation for why muscle requires
multiple nuclei is that each nucleus is capable of controlling only a
certain volume of the cytoplasm, referred to as the myonuclear
domain6–12. This thinking is consistent with the finding that
exceeding the capability of a nucleus to sustain a given cytoplasmic
volume disrupts cellular processes in organisms from yeast to
mammalian cells2,13,14. While the number of myonuclei positively
correlates with cell size in mice and humans, the threshold of
myonuclei needed to achieve target cell size and whether there is
flexibility for each of these myonuclei to maintain their cytoplasmic
domains has not been adequately explored.
Multinucleated skeletal muscle fibers form from the fusion of
progenitors during embryonic and postnatal development, and
this fusion process is required for functional skeletal muscle.
Indeed, genetic deletion of the muscle-specific fusion factors
Myomaker and Myomerger in the mouse results in death just
after birth15–18. In the adult mouse, a typical myofiber contains
hundreds of nuclei, and possesses the ability to add new myo-
nuclei in response to environmental cues owing to the presence of
skeletal muscle stem cells19. There is robust myonuclear accretion
in the mouse after birth, which slows around postnatal (P) day
2120–22. During this early time frame from P0 to P21, hindlimb
myofibers grow in length and girth, although there is a greater
increase in length compared to girth. P21 to adult is characterized
by a greater radial growth compared to length20,23, which we
define as maturational growth. Here, since myofiber volume
increases and the majority of myonuclear accretion occurs prior
to the time of maturational growth, cytoplasm:DNA ratios
increase indicating that the myonuclear domain is flexible during
this postnatal period. Additional evidence for context-dependent
myonuclear domains include that slow type I skeletal muscle
fibers exhibit smaller size but increased myonuclear number
compared to fast type II myofibers, which are larger with fewer
myonuclei24,25. Given that skeletal muscle stem cells provide a
mechanism for myofibers to accrue new nuclei through cellular
fusion, increases in the cytoplasmic volume of adult myofibers
can be achieved by regulating resident myonuclei, adding new
myonuclei, or both. The majority of evidence indicates new
myonuclei are required for functional adaptations, including
hypertrophy in the adult, suggesting limited flexibility of resident
myonuclei in adult myofibers26–31. Taken together, the decision
for muscle to either add a new myonucleus or regulate nuclei that
are already present in the myofiber is unclear and there is
minimal understanding about the requirements for the full
complement of resident myonuclei to establish functional cyto-
plasmic volumes during maturational growth.
In general, reasons for why large cytoplasmic:DNA ratios are
challenging for cells to maintain include a need to support pro-
duction and transport of sufficient synthetic material across larger
distances. Indeed, DNA becomes limiting in large yeast cells as
they are unable to appropriately scale the number of transcripts
and proteins to support the increased cellular volume, which
leads to inefficient biochemical reactions of the cell and senes-
cence2. While precise regulation of myonuclear transcriptional
capacity is not understood, there is evidence that mammalian
myonuclei exhibit a reserve capacity after muscle overload, and
Drosophila myonuclei actively adjust their size and output
depending on their location within the myofiber32,33. However,
what determines flexibility within the myonuclear compartment,
and what factors determine a functional transcriptional range
have been speculated upon but remain unknown. Currently, there
is minimal knowledge of whether DNA is limiting in mammalian
muscle cells or under which situations any potential reserve
capacity is lost or activated. Overall, the myonuclear domain is a
concept premised on early evidence that mRNA transcripts and
some myofibrillar protein products are confined to areas close to
their orginating myonuclei34,35. How such domains are estab-
lished, the associated flexibility, and a molecular understanding
for the roles of new and resident myonuclei in determining these
parameters remains to be elucidated. A major reason for this lack
of information is that studies investigating the relationship
between myonuclear number and skeletal muscle maturity and
size, especially in the neonatal period, remain correlational.
Here, we directly manipulate myonuclear accretion through
genetic deletion of the muscle fusion factor, Myomaker, at three
different neonatal timepoints to generate mice with varied numbers
of myonuclei. These novel mouse models allow a more compre-
hensive analysis of the requirement for multinucleation in mam-
malian skeletal muscle. Through assessment of the consequences of
having fewer myonuclei on establishment of muscle size and
function, we uncovered an inherent reserve capacity that can be
elicited in myonuclei during development, and is determined by the
number of nuclei in the myofiber. Our findings reveal that myo-
nuclear numbers determine not only the ultimate size of the muscle,
but also may impact the degree of flexibility it possesses.
Results
Development of mouse models with reduced myonuclear
number. We previously showed that deletion of Myomaker
(Mymk) specifically in adult muscle satellite cells results in fusion
incompetence28,36. We used these MymkloxP/loxP; Pax7CreER mice
and administered tamoxifen at either P0 or P6 to block fusion in
either the first or second week of life (Fig. 1a). Previous work
showed down-regulation of Mymk transcripts after TAM treat-
ment at P037. Because it is difficult to definitively determine the
exact point of fusion-incompetence, we refer to the mice treated
at P0 as Δ1w and mice treated at P6 as Δ2w. Analysis of nuclei
number in isolated extensor digitorum longus (EDL) myofibers
4 weeks after tamoxifen treatment revealed that Δ1w and Δ2w
mice display reduction in myonuclear numbers of 75 or 55%,
respectively (Fig. 1b, c). On average, Δ1w myofibers contained 55
myonuclei and Δ2w myofibers contained 100 myonuclei (Fig. 1b,
c), which based on previous studies indicates fusion was ablated
within the indicated timeframe20. The body weights from each
group 4 weeks after tamoxifen treatment were reduced compared
to control mice (Supplementary Fig. 1a), suggesting some effect
on skeletal muscle size. These data show that we successfully
titrated the number of nuclei in myofibers through deletion of
Myomaker in muscle progenitors during postnatal development.
Myonuclear numbers impact myofiber size parameters. The
neonatal phase of muscle growth requires myofibers to grow in
length and width, with minimal new myofiber formation20. To
understand the requirement of myonuclear accretion on these
parameters we analyzed cross-sectional area (CSA) of myofibers
in the tibialis anterior and quadriceps and evaluated myofiber
length and volume in isolated myofibers from the EDL. Δ1w
mice were analyzed at P28 and Δ2w mice at P35, each 4 weeks
after fusion was inhibited, therefore littermate control mice were
used at those ages. Histological analysis of both Δ1w and Δ2w
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mice revealed normal myofiber architecture, peripherally located
nuclei (no central nucleation), and a lack of immune cell infiltration
(Fig. 2a, b). Δ1w myofibers were visually smaller compared to control
(Fig. 2a). Quantification of CSA in Δ1w mice showed a reduction of
39% in the tibialis anterior (Fig. 2a) and 21% in the quadriceps
(Supplementary Fig. 1b). Δ2w mice exhibited a 17% reduction in the
tibialis anterior CSA (Fig. 2b) and a non-statistically significant
reduction of 15% in the quadriceps (Supplementary Fig. 1c). EDL
myofiber length was also impacted by a reduction in myonuclear
number, where Δ1w myofibers exhibited a reduction of 21% and
Δ2w myofibers were 12% shorter (Fig. 2c, d). We also measured
volume of EDL myofibers and observed a 54% reduction in Δ1w and
34% reduction in Δ2w mice (Fig. 2e, f). To understand the kinetics of
mouse and muscle growth after genetic blockade of fusion, we ana-
lyzed tibia lengths, body weights, and cross-sectional area of myofi-
bers in Δ2w mice at multiple postnatal time points. The tibia lengths
and body weights of Δ2w mice exhibited a similar change across time
compared to controls (Supplementary Fig. 2a). Tibialis anterior
myofiber size remained unchanged between WT and Δ2w mice at
P21 and P28, but an increased number of smaller fibers and
decreased number of larger fibers were apparent in Δ2w muscle at
P42 (Supplementary Fig. 2b), showing that Δ2w mice possess some
ability to grow between P28 and P42. These data indicate that a
dynamic relationship exists between number of myonuclei and radial
or length size and reveal that muscle can compensate for fewer
myonuclei.
Myonuclear number determines the type of muscle adaptation.
To determine how muscle adapts to fewer myonuclei on a
molecular level in the postnatal period we performed microarray
analysis on control, Δ1w, and Δ2w muscle at P28. Unbiased
clustering from each of the groups using principle component
analysis or hierarchical analysis separated samples based on
genotype, indicating the three groups of muscle are tran-
scriptionally different and that Δ2w is more similar to control
(Fig. 3a, Supplementary Fig. 3). Using gene ontology, we also
analyzed differentially expressed genes between control and either
Δ1w or Δ2w muscle. While both Δ1w and Δ2w muscle exhibited
increased levels of genes associated with muscle development,
these differences were more pronounced in Δ1w samples
(Fig. 3b). We also observed stark differences in gene expression
between Δ1w and Δ2w muscle in terms of fiber type specification
and apoptosis/oxidative stress. Δ1w muscle exhibited increased
levels of genes present in slow Type I skeletal muscle including
Myh7, Tnnc1, Atp2a2, and Sln (Fig. 3c). These data indicate that
Δ1w muscle does not contain the sufficient number of myonuclei
needed for establishment of a normal muscle phenotype.









































































Fig. 1 Temporal genetic ablation of Myomaker in satellite cells during development titrates myonuclear number in myofibers. a Experimental design
used to reduce myonuclear accretion during development. MymkloxP/loxP or MymkloxP/loxP; Pax7CreER mice were treated with tamoxifen (Tam.) to generate
control or fusion-incompetent mice, respectively. Tamoxifen was administered at either postnatal (P) day 0 (Δ1w) or P6 (Δ2w) and animals were
sacrificed 4 weeks post-tamoxifen. b Single myofiber images (left) and quantified average number of nuclei per myofiber (right) in control and Δ1w EDL
muscle at P28. Control myofibers had an average of 230 nuclei/myofiber, while Δ1w mice had an average of 55 nuclei/myofiber. Myonuclei are labeled
with DAPI. c Single myofiber images (left) and average number of nuclei per myofiber (right) in Δ2w and control EDL muscle at P35. Control myofibers had
an average of 225 nuclei/myofiber, while Δ2w mice had an average of 100 nuclei/myofiber. Myonuclei are labeled using DAPI. In (b) and (c), n= 3
biologically independent animals and 20 myofibers were analyzed per animal. Statistical analyses and data presentation: (b) and (c), two-sided unpaired t-
test; ****P < 0.0001. Data are reported as mean ± SD. Scale bar: 200 μm. Source data are provided as a Source Data file.
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Additionally, we observed increased levels of apoptosis and oxi-
dative stress genes in Δ1w muscle suggesting that a 75% reduction
of myonuclei results in a maladaptive phenotype (Fig. 3d).
Indeed, Δ1w mice die by 200 days of age (Fig. 3e). At 5 months of
age, Δ1w mice are hunched and display kyphosis, further indi-
cating that this level of myonuclear number is not sustainable for
normal muscle function (Fig. 3f). In contrast, we did not observe
obvious kyphosis in Δ2w mice at 5 months of age (Fig. 3f) and no
premature death during the duration of this study (Fig. 3e).
Overall, the level of myonuclei in Δ1w muscle is not sufficient to
establish normal muscle and leads to a maladaptive phenotype,
but the level of myonuclei in Δ2w muscle is sufficient to elicit an
adaptation that allows survival and relatively normal develop-
ment under baseline conditions.
mRNA analysis reveals a range of myonuclear flexibility. Since
Δ1w and Δ2w mice possess fewer myonuclei, but these nuclei lack
any genetic perturbation and therefore are genetically normal, we
surmised that the adaptive responses elicited in these models
could help determine the potential range of functional myo-
nuclear flexibility. To that end, we explored total RNA and
mRNA levels of the various groups of mice to understand the
relationship between myonuclear number and mRNA output.
Total RNA normalized to muscle weight (RNA abundance)
revealed no differences between WT, Δ1w, and Δ2w mice at P28
(Fig. 4a). However, when these values were further normalized to
the average myonuclear number, a 4-fold increase is revealed in
Δ1w muscle and a 2-fold increase in Δ2w muscle (Fig. 4b). These
data indicate that in Δ1w and Δ2w muscle there are a greater ratio
of RNA:myonuclei compared to WT muscle, suggesting muscles
with fewer nuclei are able to positively regulate RNA abundance.
To test if this ability impacted mRNA content, we assessed levels
of mRNA transcripts from our microarray analysis and normal-
ized them to total RNA and average myonuclear numbers. The
normalization of mRNA transcripts to total RNA yields a metric
for mRNA concentration (relative to total RNA content, not
volume), which has shown to be size-independent in mono-
nuclear cells3. We found that, when compared to controls, Δ1w
muscle possessed an increased mRNA concentration of 1.25-fold,
whereas Δ2w muscle increased 1.5-fold (Fig. 4c). The greater
increase in mRNA concentration in Δ2w muscle is consistent
with the idea that they possess a more effective and sustainable
adaptive response. Indeed, when assessed on a per nuclear basis
(as a proxy for the relative mRNA output per nucleus), this value
was appreciably higher in Δ1w muscle (5.3-fold) compared to
Δ2w muscle (3.5-fold) (Fig. 4d). We interpret the premature
death of Δ1w mice as evidence that this level of transcriptional
output is either not sustainable or dysfunctional. In contrast, the
absence of premature lethality in Δ2w mice coupled with estab-
lishment of smaller but functionally normal muscle (see below)
indicates that the increase in relative mRNA output per nucleus
in these mice is within a manageable range of flexibility. These
data show that myofibers with fewer myonuclei exhibit flexibility
in terms of ability to increase mRNA concentrations and also
establish a minimal number of nuclei required for muscle
development that can sustain life.
Δ2w mice exhibit larger and functional cytoplasmic domains.
Since Δ1w mice die prematurely, we focused further analysis on a








































































































































































































Fig. 2 Effects of myonuclear reduction on myofiber dimensions. a Representative sections of tibialis anterior (TA) muscle of Δ1w and control mice at P28
(left). Analysis of cross-sectional area (CSA; right) revealed a 39% reduction in Δ1w myofiber CSA compared to controls. b Sections of TA muscle of Δ2w
and control mice at P35 (left). CSA analysis (right) showed Δ2w myofibers are 17% smaller than controls. Sections in (a) and (b) were immunostained
with laminin antibodies (red) and also stained with DAPI to label nuclei (white). c, d Average length of Δ1w EDL myofibers is decreased by 21% compared
to controls (c), and Δ2w EDL myofiber length is decreased by 12% (d). e, f Myofiber volume showed a 54% reduction in Δ1w EDL at P28 (e) and a 34%
reduction in Δ2w EDL at P35 (f). At least 3 20× images were analyzed per mouse in (a) and (b) (n= 4–5 biologically independent animals). 20 myofibers
were analyzed per animal in (c–f) (n= 3–4 biologically independent animals). Statistical analyses and data presentation: (a–f) two-sided unpaired t-test;
*p < 0.05, **p < 0.01. Data are represented as mean ± SD. Scale bar: 50 μm. Source data are provided as a Source Data file.
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we asked: (1) if the compensation observed during early devel-
opment is sustained and able to support maturational growth
(from adolescence to adulthood), when there is limited addition
of new myonuclei, and (2) how the myonuclear domain is
impacted by the the reduction in myonuclei numbers. We began
by analyzing isolated EDL myofibers from control and Δ2w
muscle at multiple time points from P13 to P150. This approach
allowed determination of nuclear number, cross-sectional area,
and myonuclear domain from the same sample material. A
200–400-µm segment from at least 30 myofibers per animal was
imaged and rendered in 3D (Fig. 5a), which was then utilized for
quantification of multiple parameters. The myonuclear number in
Δ2w muscle was reduced at P14, one week after ablation of
fusion, and remained reduced through P150 (Fig. 5b). These data
show that the myonuclear number in Δ2w muscle is not rescued
through karyokinesis of existing myonuclei or through fusion of a
Pax7-independent stem cell population. The cross-sectional area
of EDL myofibers begins to diverge at P35 in Δ2w muscle and
remains reduced at P42 and P150 (Fig. 5c). However, between
P42 and P150 we observed an increase in CSA of both control
and Δ2w muscle suggesting that muscle with fewer nuclei can
grow in width during the maturational phase of muscle growth.
Analysis of myonuclear domains in the isolated EDLs revealed
larger cytoplasm:DNA ratios in Δ2w muscle beginning at P28,
and this difference increased at P150 (Fig. 5d). These data
indicate that muscle fibers with a 55% reduction in nuclei and
expanded cytoplasm:DNA ratios can grow radially during the
maturational growth phase of muscle development.
As an independent method to determine the ability of Δ2w mice
to grow and function during maturation from P42 to adulthood,
we analyzed cross sections of the tibialis anterior and evaluated
function of hindlimb muscles. Consistent with our findings in the
EDL, tibialis anterior cross-sectional area of Δ2w muscle increased
by a similar percentage as control between P42 and P150 (Fig. 5e).
Assessment of muscle function using an in situ approach that
directly measures force produced by the tibialis anterior revealed
reduced peak force in Δ2w mice, consistent with their muscles
being smaller than controls (Fig. 5f). However, specific force (peak
force normalized to physiological cross-sectional area) and fatigue
were comparable between control and Δ2w mice (Fig. 5f).
Moreover, functional analysis on skinned single myofibers from
the TA revealed similar specific force between control and Δ2w
mice (Fig. 5g). One aspect of Δ2w muscle that could compensate
for function are changes in fiber type, but we observed normal
distributions of myosin isoforms (Supplementary Fig. 4).
Thus, our combined functional analysis indicates normal
myofiber quality in Δ2w mice. Consistent with normal specific
force, Δ2w muscles contain normal relative levels of contractile
proteins that comprise the muscle sarcomere (Fig. 5h). Taken
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Fig. 3 Δ1w mice display a maladaptive lethal phenotype in contrast to Δ2w mice. a PCA plot from microarray analysis showing the differential clustering
of Δ1w, Δ2w, and control samples (TA muscle). Δ1w muscle displayed a more divergent profile from that of Δ2w and control muscle, which appeared
more similar. b Heat map of muscle development genes showed more pronounced alterations in Δ1w compared to Δ2w muscle. c Heat map of genes
associated with muscle fiber type revealed Δ1w muscle exhibit increased expression of slow fiber type genes (Myh7, Tnnt1, Atp2a2, Sln) and reduced
expression of fast fiber type genes (Myh4, Myh1). d Heat map showing increased expression of apoptosis and oxidative stress genes in Δ1w muscle.
e Survival curve for Δ1w, Δ2w, and control mice. Δ1w mice began dying prematurely prior to three months of age while Δ2w mice did not. f Images of Δ1w,
Δ2w, and control mice showed kyphosis in Δ1w mice, while Δ2w mice looked similar to controls. Data presentation: (a–d) data generated using microarray
data performed on TA muscle at P28; n= 3 per group. Scale bar: 2 cm. Source data are provided as a Source Data file.
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leading to smaller myofibers, but expanded myonuclear domains
and the ability to develop specific force comparable to controls.
These data establish that a reserve capacity to support expanded
myonuclear domains and functional growth exists in myonuclei
during postnatal development.
Myonuclear number limits myofiber flexibility. We have shown
that Δ2w mice consistently possess an increased mRNA con-
centration (relative to total RNA content, not volume) in muscle,
even though they contain fewer nuclei. Thus, compared to control
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Fig. 4 Myofibers adapt to the reduction in myonuclear numbers by elevating mRNA concentrations. a Total RNA levels from the tibialis anterior
normalized to muscle weight for the indicated groups of mice at P28. b Normalized RNA levels (from a) further normalized to the average number of
nuclei/myofiber. For (a) and (b), n= 3–8 biologically independent animals. c Comparison of the mRNA concentration (normalization of sst-rma signals
from microarray of 22,207 annotated transcripts to total RNA for the respective sample) of Δ1w and Δ2w muscle to control revealed a greater contribution
of mRNA to total RNA (mRNA concentration) being generated in both Δ1w (slope= 1.2504) and Δ2w (slope= 1.519) muscle (represented as the slope of
the best-fit line). d Data from c were normalized further to average number of nuclei/myofiber, revealing an even larger increase in the percentage of
mRNA:total RNA being generated on a per nucleus basis in Δ1w (slope= 5.2971) and Δ2w (slope= 3.5393) muscle compared to controls. Statistical
analyses and data presentation: (a) and (b), one-way ANOVA with a Tukey correction for multiple comparisons; *p < 0.05, ****p < 0.0001. Significance
compared to control group. Data are reported as mean ± SD. Source data are provided as a Source Data file.
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concentrations and larger myonuclear domains. One potential
explanation of these data is simply that a reduction in myonuclear
numbers elicits the adaptive flexibility observed in the Δ2w mice.
To further test the relationship between myonuclear number and
flexibility to establish size, we generated a mouse model with
more nuclei than Δ2w mice but less than control. To achieve this,
we treated MymkloxP/loxP; Pax7CreER or MymkloxP/loxP (as con-
trols) with tamoxifen at P13 (Fig. 6a), the final week during
development where robust myonuclear addition takes place. In
these mice, which we refer to as Δ3w, analysis of myonuclear
number in isolated EDLs showed that these myofibers exhibit a
25% reduction of nuclei (Fig. 6b). Thus, Δ3w muscle have a
nuclear number (approximately 180/myofiber) between control
(233/myofiber) and Δ2w (100/myofiber). Body weights of Δ3w
mice were smaller compared to controls (Supplementary Fig. 5a).
We analyzed size parameters of muscle in Δ3w mice at P42,
4 weeks after ablation of fusion, and found a 22–24% reduction of
cross-sectional area in the tibialis anterior and quadriceps
(Fig. 6c, Supplementary Fig. 5b). We also observed a 9% reduc-
tion of EDL length in Δ3w mice (Fig. 6d) and a 33% reduction in
volume (Fig. 6e).
To directly compare size regulation in Δ2w and Δ3w muscle we
analyzed cross-sectional area at P42 as a percentage of littermate
controls. Here we found that both Δ2w and Δ3w muscle exhibited
a reduction in size despite Δ3w muscle containing more
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isolated EDL myofibers was not different from control myofibers
(Fig. 7b). Δ3w mice possess the same myonuclear domain as
controls, but with fewer nuclei, resulting in smaller muscle. That
Δ2w and Δ3w muscle exhibited similar size, but with divergent
effects on cytoplasm:DNA ratios, prompted us to compare
mRNA concentrations per nucleus, as a measurement of
flexibility, between the two models. At P42, there were no
differences in total RNA of the tibialis anterior when normalized
Fig. 5 Δ2w mice retain the ability to generate normal muscle quality with enlarged myonuclear domains. a Representative images showing 3D rendered
myonuclei (blue) and myofiber volume (gray) from a section of control and Δ2w EDL myofibers at P35, viewed from the side (top) and through (bottom)
the myofiber. Images were used to quantify nuclei number, myofiber area and myonuclear domain. b Number of myonuclei/mm in EDL myofibers from the
indicated groups of mice at various ages. c EDL myofiber cross-sectional areas in control and Δ2w muscle. d Quantification of changes in myonuclear
domain in control and Δ2w EDL myofibers over time. b–d n= 3–5 biologically independent animals. e Comparison of tibialis anterior (TA) cross-sectional
area at P42 and 5 months, expressed as growth over time (left), and percentage of control (right), revealed the retained ability of Δ2w muscle to grow at
the same rate as control muscle. n= 5–10 biologically independent animals. f Control and Δ2w muscle were subjected to in situ muscle force
measurements to assess functional capacity at five months of age. Δ2w tibialis anterior generated a lower peak tetanic force (left), but when normalized to
physiological cross-sectional area, Δ2w muscle exhibited similar specific force as controls (middle), indicating the overall functional quality of muscle in the
two groups is the same. Fatigue, measured as loss of initial force following continuous isometric stimulations, was similar between the two groups (right).
n= 5–15 biologically independent animals. g Contractile function of single myofibers from control and Δ2w tibialis anterior muscles. 6 myofibers were
analyzed per animal. n= 3 biologically independent animals. h Representative western blots for myosin and sarcomeric actin from control and Δ2w
quadriceps (top). Quantification of the protein signal normalized to GAPDH (bottom). n= 4 biologically independent animals. Statistical analyses and data
presentation: (b–d) two-way ANOVA with a Tukey correction for multiple comparisons. e–h Two-sided unpaired t-test; *p < 0.05, **p < 0.01, ***p < 0.001,










































































































































Fig. 6 Size characteristics in Δ3w mice. a Experimental design used to generate a third genetic model, Δ3w mice. The indicated groups of mice were
administered tamoxifen (Tam.) at P13 and tissue was collected four weeks later. b Single myofiber images (left) and quantified average number of nuclei
per myofiber (right) in Δ3w and control EDL muscle at P42. Control myofibers have an average of 246 nuclei/myofiber, while Δ3w mice have an average
of 180 nuclei/myofiber. Myonuclei are labeled with DAPI. c Representative sections of Δ3w and control tibialis anterior (TA) muscle at P42 (left). Analysis
of cross-sectional area (right) showed Δ3w myofibers are 22% smaller than controls. Sections in (c) were immunostained with laminin antibodies (red)
and stained with DAPI (white). d Average length of Δ3w EDL myofibers is decreased by 9% compared to controls. e Myofiber volume showed a 33%
reduction in Δ3w EDL at P42. 20 myofibers were analyzed per animal (n= 3 biologically independent animals) in (b), (d), and (e). At least 3 20× images
were analyzed per mouse in (c) (n= 6 biologically independent animals). Statistical analyses and data presentation: (b–e) two-sided unpaired t-test; *p <
0.05, **p < 0.01. Data are represented as mean ± SD. Scale bars: (b) 200 μm, (c) 50 μm. Source data are provided as a Source Data file.
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to tissue weight between control, Δ2w, and Δ3w mice (Fig. 7c).
When this value was further normalized to average myonuclear
number, we observed an increase in Δ2w muscle, confirming our
observations obtained at P28; in contrast, no such increase was
detected in Δ3w muscle (Fig. 7d). While relative output of
sarcomeric transcripts on a per nuclear basis were increased in
both Δ2w and Δ3w muscle, the magnitude was modest in Δ3w
compared to Δ2w muscle (Fig. 7e). These data reveal that a
reduction of myonuclear numbers elicits an increase in mRNA
output on a per nuclear basis in both Δ2w and Δ3w mice.
However, Δ3w muscles, which contain 1.8-fold more nuclei, do
not achieve the magnitude of output observed in Δ2w muscles.
These data indicate that Δ3w muscle also has an ability to
increase relative mRNA output compared to controls, but not to
levels sufficient to enlarge myonuclear domains or establish
muscle size to control levels. Overall, we interpret the diminished
adaptive response observed in Δ3w muscles to indicate that
myonuclear flexibility (an ability to sustainably enhance mRNA
concentrations and support larger cytoplasmic volumes), seems
to be determined directly by the number of myonuclei.
Cellular volume has also been proposed to be sensed by nuclei
and result in increased output38. While our data indicate that
nuclei number itself regulates output, we sought to also test the
effect of volume, in a setting where nuclei numbers are not
increased, on myonuclear flexibility. Genetic and pharmacologic
inhibition of myostatin, a negative regulator of muscle mass, leads
to increases in myofiber size but does not elicit myonuclear
accretion24,29,39,40. We treated 3-month-old control and Δ2w
mice with ACVR2B-Fc, a decoy receptor for myostatin, over
4 weeks (Supplementary Fig. 6a). Control and Δ2w mice
exhibited hypertrophy of myofibers to similar levels (Supplemen-
























































































































































































































Fig. 7 Flexiblity is inversely correlated with myonuclear number. a A comparison of the cross-sectional area of tibialis anterior muscle in Δ2w and Δ3w
mice at postnatal (P) day 42 revealed similar effects on cell size, despite differences in myonuclear number (n= 3–7 biologically independent animals).
b Assessment of the myonuclear domain in isolated EDL myofibers from Δ3w mice at P42 (n= 3 biologically independent animals). c Total RNA levels
normalized to muscle weight in the various groups of mice (n= 5–10 biologically independent animals). d Normalized RNA levels from (c) were normalized
again to the average number of nuclei/myofiber (n= 5–10 biologically independent animals). A significant increase in the amount of RNA per myonucleus
is observed in Δ2w muscle, but remains unchanged in Δ3w muscle. e Concentration of transcripts coding for key skeletal muscle structural genes (Acta1,
Myh1, Myh4, Tnnt3, and Tnnc2) on a per nuclear basis are increased in Δ2w and Δ3w muscle compared to controls (n= 3–8 biologically independent
animals). Δ2w muscle has a larger increase in transcript concentration per nucleus than Δ3w, despite having fewer myonuclei per fiber. To obtain these
values, relative transcript levels were determined by semi-quantitative qPCR from P42 samples, which were then normalized to total RNA and average
myonuclear numbers for each genotype. f Abundance of transcripts on a per nuclear basis in wild-type tibialis anterior across developmental time points
(n= 3–7 biologically independent animals). Statistical analyses and data presentation: a, two-sided unpaired t-test. c, d One-way ANOVA with a Tukey
correction for multiple comparisons; significance compared to control group. e, Acta1 (both groups), Myh1 (Δ2w only): Mann–Whitney test. Myh1 (Δ3w
only), Myh4, Tnnt3, and Tnnc2 (both groups): two-sided unpaired t-test with Welch’s correction. f One-way ANOVA with Tukey correction for multiple
comparisons. Acta1 was analyzed with one-way ANOVA with Kruskal–Wallis correction for multiple comparisons. *p < 0.05, **p < 0.01, ***p < 0.001,
****p < 0.0001. Data are represented as mean ± SD. Source data are provided as a Source Data file.
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(normalizing mRNA to average numbers of myonuclei) for
sarcomeric genes was observed after ACVR2B-Fc treatment in
either control or Δ2w mice (Supplementary Fig. 6d). The failure
to increase mRNA output by ACVR2B-Fc may explain the
reduced muscle quality in animals where myostatin has been
inhibited24,40. These data suggest that stimuli which lead to
increases in myofiber volume, such as with myostatin inhibition,
cannot be assumed to drive global increases in mRNA output.
Overall, our data indicate that the number of nuclei predominate,
over other factors such as volume, in determining myonuclear
flexibility and mRNA concentrations.
The data presented thus far indicate that addition of myonuclei
do not always yield an increase in output per nucleus, but these
observations were made in genetic models. When extrapolated to
normal postnatal muscle development, the sum total of our data
suggest a paradigm where increase in myonuclear numbers
during this period does not correlate with increase in cellular total
mRNA abundance. If true, increases in mRNA abundance on a
per nuclear basis should be limited during these postnatal
developmental phases. To test this paradigm, we analyzed
transcript abundance of Acta1, Myh1, Myh4, Tnnt3, and Tnnc2
in control muscle during developmental myonuclear accretion
(P14 and P21) and also, after the majority of that process had
terminated (P28 and P42). Note that we were not assessing
myonuclear flexibility here because there is no genetic perturba-
tion to reduce nuclei numbers, and therefore did not measure
mRNA concentrations. Consistent with our hypothesis, we found
that despite an increase in myonuclear numbers between P14 and
P21, transcript abundance on a per nuclear basis did not increase
for any of the genes analyzed (Fig. 7f). Increases detected at P28
and P42 (Fig. 7f) indicate that myofibers retain the ability to
globally upregulate mRNA abundance from resident myonuclei
during maturational growth.
Discussion
Our study begins to unravel the relationship between myonuclear
number, achievement of target size, and determinants of myofiber
flexibility in multinucleated fast skeletal muscle. The results presented
here show that myonuclear numbers are the ultimate determinant of
size in mammalian skeletal muscles. However, our data indicate that
just increasing the number of myonuclei would not result in a
commensurate increase in muscle size or volume. Therefore, the
relationship between myonuclei numbers and myofiber size is not a
simple linear one, a concept that has been independently validated in
an accompanying manuscript41. Through analysis of mRNA con-
centration and output per nucleus in mice where myonuclei numbers
were titrated, we determined a range of myofiber flexibility that could
sustain muscle quality. On a per nucleus basis, Δ1w mice generated
more mRNA but had a maladaptive compensation with reduced
mRNA concentration compared to Δ2w mice. These data suggest
that dysregulation of the mRNA transcriptional profile in Δ1w mice
may underlie the kyphosis and early lethality and indicate that these
mice have not reached the threshold of myonuclear numbers
necessary for establishing functional muscle. In contrast, Δ2w mice
are able to grow and maintain functional muscle, indicating that the
increase in mRNA concentration and output per nucleus is within a
healthy and sustainable range. These findings suggest a threshold
number of myonuclei that are necessary for their reserve capacity to
be effectively utilized to support myofiber flexibility during
development.
Despite exhibiting smaller myofibers with reduced absolute
force, Δ2w mice display normal gross structure and development
of specific force comparable to controls. In an accompanying
manuscript41, we show that the larger fibers of the Δ2w mice
display less DNA content (nuclear number) per fiber volume
relative to smaller fibers, and thus exhibit a type of scaling that
takes the form of power laws. Specifically, nuclear number
maintains a one-to-one pace with fiber surface area, but nuclei are
able to sustain higher functional fiber volumes with increments in
myofiber size. However, we are unable to exclude that other
aspects of muscle function could be impaired by the reduced
number of nuclei. For instance, these mice might be more
impacted during aging or they may not be able to respond
appropriately to stresses such as exercise. It is difficult to assess if
the Δ2w mice could respond to exercise since that stimulus may
acutely require satellite cell fusion26,28,29, and the Δ2w mice not
only possess fewer myonuclei but also an inability to add new
myonuclei in the adult because the deletion of Myomaker in
satellite cells is indelible. New mouse models and techniques will
be required to fully explore the limits of myofiber flexibility in
mice where myonuclear numbers are titrated.
One of the most interesting aspects of our study is the com-
parison between Δ2w and Δ3w mice. We anticipated that the
deficiency of myonuclear numbers in Δ3w mice would elicit an
adaptive response as was observed in Δ2w mice, which have a
55% reduction in myonuclei but achieve 65% of WT volume, with
an associated increase in mRNA concentrations. We reasoned
that such an adaptive upregulation in transcriptional output in a
larger population of myonuclei (Δ3w mice had a 1.8-fold increase
in myonuclei compared to Δ2w mice) would result in full com-
pensation and establishment of WT myofiber size. However,
while evidence of elevated mRNA concentrations was found in
Δ3w mice, those increases do not remotely reach what was
achieved in Δ2w mice, and Δ3w mice do not achieve a similar size
as controls. Thus, the inability to establish normal WT size in
Δ3w mice is a consequence of having fewer nuclei and inadequate
flexibility. An alternative explanation is that the identity of nuclei,
not overall number, is the primary factor driving the differences
in flexibility between Δ2w mice and Δ3w mice. However, since
Δ3w mice exhibit some flexibility, just less than what is achieved
in Δ2w mice, we propose that myonuclear number controls
adaptation through modulation of overall flexibility. Specifically,
that when more nuclei are added to the syncytium, overall output
may increase, but each nucleus contributes progressively less.
This paradigm suggests a potential cost of having myofibers
rich in nuclei is that it limits the range of myonuclear flexibility,
indicating an unexpected inverse relationship between myo-
nuclear numbers and an ability to upregulate mRNA con-
centration. This could be caused by direct negative influences
between the nuclei or may result from increasing nuclei numbers
competing for essential but limited transcription factors. Work on
mammalian cells forced to form heterokaryons has implicated the
existence of a factor that helps modulate transcription, providing
support for the idea that nuclei can negatively regulate output
from other nuclei in a syncytium38. The identity of a factor that
could regulate transcriptional output between nuclei is not known
in any system. Another question that remains to be answered is
whether the adaption of increased mRNA concentration in Δ2w
mice is due to enhanced mRNA production and/or diminished
mRNA degradation. Also, elegant work in Drosophila showed
that myonuclei exhibit the ability to endoreplicate33, but endor-
eplication has not been detected during normal postnatal devel-
opment in mammals rats42,43. Consistent with mammalian
myonuclei not being able to endoreplicate, we did not detect
changes in nuclear volume, an indicator of genome content, in
Δ2w mice41.
Our models where myonuclear numbers have been titrated
may explain the conundrum of myonuclear flexibility during
development and inflexibility in the adult. Based on multiple
studies where the function of muscle stem cells was genetically
inhibited, accrual of new myonuclei is required for adult
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adaptations including hypertrophy26–31. Thus, in the adult there
seems to be limited flexibility of hundreds of myonuclei that were
added during development to increase mRNA concentration,
although there is an ability to upregulate rRNA44. The divergence
in outcomes between the Δ2w and Δ3w models reveal that having
more nuclei limits overall myofiber flexibility. The retention of
such limiting mechanisms in adult myofibers would account for
the observed reliance on myonuclear accretion for adaptability,
and suggest that acquisition of new nuclei to adapt is more
economical than globally upregulating transcription in all resi-
dent myonuclei. Specifically, in situations where the stimulus is
mild or localized to a specific domain of the myofiber, such as
exercise-induced injury29, developmental growth in length20, and
regulation of the neuromuscular junction45, accrual of nuclei
from the stem cell population may preferentially occur as global
upregulation of transcriptional output is unnecessary and was-
teful. In contrast, in situations where the stimulus is sensed
throughout the myofiber, such as maturational growth (P21 to
adult), where global upregulation of mRNA output is necessary,
hypertrophy occurs without an absolute reliance on accrual of
new nuclei. While myofibers clearly have the potential to establish
domains of myonuclei that harbor different transcriptional pro-
files, such as at the neuromuscular junction and myotendinous
junction12,46–48, myofibers may not possess the ability to selec-
tively modulate transcriptional output from resident myonuclei in
microdomains related to properties that are more globally regu-
lated such as radial size and force.
In this report, we study growth of muscle in multiple dimen-
sions. Growth of muscle length during neonatal development
coincides with the timing of myonuclear accretion, therefore we
were surprised by the stronger effect of myonuclear titration on
radial size compared to length in hindlimb muscles. We pre-
viously showed that Δ1w mice do not develop neuromuscular
contractures, a syndrome associated with shorter skeletal mus-
cle37. However, shorter myofibers could be compensated for by
pennation angles and tendon length, yielding a functional joint
absent of contractures. Overall, the relatively mild effect on
myofiber length with only 25% of WT myonuclei could be
explained by the idea that there is maximal pressure on the
muscle to grow in length during this period because of bone
growth. Thus, while normal length of individual myofibers
require the full amount of nuclei this can be compensated for to
make sure muscle growth keeps pace with bone growth.
One limitation of our study is that we mainly focus on the
regulation of mRNA for muscle growth and do not deeply
investigate protein synthesis and degradation, which are critical
for regulation of muscle size49,50. The reason for the focus here on
mRNA is that the main perturbation in our models is at the level
of nuclei, which determine the number of templates available for
protein generation. Relative myosin and sarcomeric actin levels
were unchanged in Δ2w muscle when normalized to GAPDH.
However, when these protein levels were normalized to muscle
weights, Δ2w muscle would exhibited an increase (~1.5-fold; not
shown) that mirrored the increase observed in mRNA con-
centrations. This could imply a proportional increase in both
transcript and protein levels of key contractile factors, which
exceed the amount of protein incorporated into functional sar-
comeres. Overall, we anticipate that future work will reveal
proteostasis-related adaptations in the Δ2w mice.
Finally, these results also advance our knowledge of myo-
nuclear domains in myofibers, the defined cytoplasmic volumes
controlled by each of the hundreds of resident myonuclei. We
propose that during postnatal development, robust myonuclear
accretion correlates with myofiber growth in length. Once the
majority of length growth has been achieved, there is not a
requirement for robust myonuclear accretion, but now muscle
has a plethora of nuclei that can contribute to maturational
growth. Our results indicate that the magnitude of that con-
tribution is defined by the mRNA output on a per nuclear basis,
the range of which appears to be determined by the number of
myonuclei present. The limits of this range define the size of
myonuclear domains that can be supported during maturational
growth, or regrowth in adults after hindlimb suspension is
reversed, where there is significant hypertrophy without accretion
of new myonuclei51,52. The paradigm that nuclei within each fiber
limits flexibility of individual resident myonuclei would account
for the near obligatory reliance of adult muscle myofibers on
myonuclear accretion for adaptations. Future experiments tar-
geting transcriptional output will clarify this and other concepts
highlighted by the current work, with the potential to redefine our
understanding of myonuclear domains, size regulation, and
adaptive flexibility in multinucleated muscle cells. Understanding
the molecular circuitry for the reserve capacity in our models with
titrated myonuclear numbers could help design novel strategies to
maintain muscle mass without the need for accretion from the
muscle stem cell pool.
Methods
Animals and tamoxifen treatment. To ablate myomaker specifically in muscle
satellite cells, MyomakerloxP/loxP mice were bred with mice carrying the muscle
stem cell-specific Pax7CreER conditional Cre recombinase. MyomakerloxP/loxP;
Pax7CreER mice represented the experimental group, while MyomakerloxP/loxP mice
served as controls. Tamoxifen (Sigma-Aldrich) was dissolved in corn oil with 10%
EtOH and administered to all mice by intraperitoneal (IP) injections. Neonatal
dosage of tamoxifen was 200 μg (Δ1w and Δ2w mice) or 300 μg (Δ3w mice). For all
groups, equal ratios of both male and female mice were used. Mice were housed in
a room with an ambient temperature of 72 °F, with 30–75% humidity, and a 10/14
h dark/light cycle. All animal procedures were approved by Cincinnati Children’s
Hospital Medical Center’s Institutional Animal Care and Use Committee.
Muscle collection and preparation. To collect muscles for analysis, mice were
anesthetized using isoflurane and then cervical dislocation was performed. Muscles
were harvested, weighed, and then either flash frozen in liquid nitrogen for
molecular analysis, or embedded in tragacanth and frozen in liquid nitrogen-
chilled 2-methylbutane for downstream histological analysis. Some cohorts of
muscle (both control and experimental) were collected and fixed in 4% paraf-
ormaldehyde (PFA)/PBS for 3–4 h, then cryoprotected in 30% sucrose/PBS over-
night. Muscles were then embedded in OCT and frozen in liquid nitrogen-chilled
2-methylbutane prior to sectioning. All muscles used for histology were cryosec-
tioned at 10 μm thickness at the muscle mid-belly.
Immunohistochemistry and quantification of myofiber cross-sectional area
(CSA). Muscle sections were first fixed in 1% PFA for 2 min, washed in PBS,
permeabilized in 0.2% Triton X-100/PBS for 10 min, washed in PBS, and blocked
in 1% BSA/1% heat inactivated goat serum/0.025% Tween20/PBS for 1 h at room
temperature in a humidity chamber. Next, slides were incubated in rabbit anti-
laminin primary antibody (1:100; Sigma-Aldrich) for 1 h at room temperature, or
overnight at 4 °C, in a humidity chamber. After incubation in primary antibody,
slides were washed in PBS, and incubated in goat anti-rabbit Alexa Fluor
647 secondary antibody (1:200; Invitrogen) for 30–60 min at room temperature in
a humidity chamber. Slides were then washed with PBS and mounted with Vec-
taShield containing DAPI (Vector Laboratories). After immunostaining, repre-
sentative images were taken on a Nikon A1R confocal microscope for use in CSA
analysis. The CSA of individual myofibers were measured using NIS Elements
software (Nikon), which can quantify the area within laminin-labeled myofibers.
After all CSA measurements were collected, CSA distribution graphs were gener-
ated by binning all data to produce a parametric distribution in control groups, and
then comparing experimental distributions using the same binning.
Immunohistochemistry and quantification of fiber type distribution. Muscle
sections were first fixed in 1% PFA for 2 min, washed in PBS, permeabilized in
0.2% Triton X-100/PBS for 10 min, washed in PBS, and blocked in 1% BSA/1%
heat inactivated goat serum/0.025% Tween20/PBS with AffiniPure Fab Fragment
goat anti-mouse IgG diluted 1:50 for 2 h at room temperature in a humidity
chamber. Next, slides were co-incubated with primary antibodies against MYH7
(1:50; BA-D5, DSHB), MYH2 (1:20; SC-71, DSHB), MYH4 (1:10; BF-F3, DSHB),
and rabbit anti-laminin (1:100; Sigma-Aldrich) overnight at 4 °C in a humidity
chamber. After incubation in primary antibodies, slides were washed in PBS, and
co-incubated in goat anti-mouse IgG2b Alexa Fluor 594 (1:100; Invitrogen), goat
anti-mouse IgG1 Alexa Fluor 647 (1:100; Invitrogen), goat anti-mouse IgM Alexa
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Fluor 488 (1:100; Invitrogen), and goat anti-rabbit Alexa Fluor 405 (1:200; Invi-
trogen) secondary antibodies for 90 min at room temperature in a humidity
chamber. Slides were then washed with PBS and mounted with VectaMount
permanent mounting medium (Vector Laboratories). After immunostaining,
representative images were taken on a Nikon A1R confocal microscope for use in
fiber type analysis. Fibers were analyzed for which antibody was stained most
dominantly, with unlabeled myofibers counted as TypeIIx. Analysis was completed
using FIJI (ImageJ).
Single myofiber isolation and nuclei count. EDL muscles were collected and
incubated in high-glucose DMEM (HyClone Laboratories) with 0.2% collagenase
type I (Sigma-Aldrich) at 37 °C in a cell culture incubator. After 30–45 min of
incubation, muscles were gently triturated using a wide bore glass pipette to loosen
digested myofibers, and then returned to the incubator. After no more than a 1-
hour incubation, muscles were triturated (first using a wide bore, then a small bore
pipette) until myofibers shed from muscle. Single myofibers were collected and
fixed in 4% PFA/PBS for 20–30 min at room temperature, and subsequently stored
in PBS at 4 °C. To immunostain nuclei with DAPI, myofibers were permeabilized
and blocked in 5% goat serum/2% BSA/0.2% Triton X-100/PBS for 10 min at room
temperature, inverting. Next, myofibers were washed three times with PBS and
mounted with VectaShield containing DAPI (Vector Laboratories). Myofibers were
imaged using a Nikon SpectraX widefield microscope. Nuclei were counted and
myofiber length was measured in 3D reconstructed images using Imaris software
(Bitplane). Raw number of myonuclei per fiber and myofiber length was recorded,
and these data were used to determine the average number of myonuclei per fiber
in each condition. For Figs. 2 and 6, myofiber volume was determined by mea-
suring fiber diameter at five spots along the length of the fiber, using the average
diameter to calculate cross-sectional area of the fiber, and multiplying that by the
length of each fiber.
For analysis in Fig. 5a–d, myofibers were stored in 1% PFA before being
transferred to a petri dish with distilled water. Single fibers were placed on a glass
slide (Superfrost Plus, Thermo Fisher Scientific) and the slides were mounted by a
glass cover slip (No. 1.5, Marienfeld) with DAPI Fluoromount-G (Southern
Biotech) to visualize nuclei. Slides were dried overnight and sealed with nail polish
and stored no longer than 2 days before imaging. Images were acquired with a 40×
oil immersion objective (CPI, Plan Fluor, NA 1.3) on an Andor DragonFly (Andor,
Oxford Instruments) confocal microscope with a Zyla4.2 sCMOS camera with a x–
y resolution of 0.3 × 0.3 μm2 and z step size of 1 μm. Lasers with emission
wavelength 405 nm (DAPI), 488 and 561 nm were used. Pixel binning of 2 × 2 was
used to reduce time of image acquisition and improve signal-to-noise ratio. 25–40
cells from each muscle were analyzed. Imaged segments along the fibers were
chosen visually from a straight section from the mid 1/3 of each fiber, excluding
NMJ and MTJ regions. Nuclear number and cellular volume were analyzed using
the Imaris Bitplane 9.20 software (Oxford Instruments). Using the spot function in
Imaris, a spot was automatically assigned to each nucleus based on the fluorescence
intensity from DAPI, followed by manual corrections. Volume and surface
rendering were performed using the tissue autofluorescence in the red and green
channel. Rendering of cellular geometry was performed using the fluorescence
perimeter border of the cell in the cross-sectional direction as an outer limit,
thereby preserving cell morphology during quantification.
In situ muscle force measurements. At 5 months of age, isometric force of the
tibialis anterior (TA) muscle was measured in both control and Δ2w mice. Animals
were anesthetized using isoflurane and kept warm under a radiant heating lamp
throughout the experiment. An incision parallel to the femur was made to expose
and cut the distal portion of the sciatic nerve close to the hip. The tibia branch of
the sciatic nerve at the knee was also cut, allowing for stimulation of the peroneal
nerve leading to the TA muscle. The distal TA tendon was severed, and the lower
1/3 of the muscle was released from the tibia. Blood circulation to the TA remained
intact, and the portion of TA still connected to the tibia remained under the facia,
which kept its temperature and moisture. The leg was immobilized at the knee
using the limb clamp, and the foot was secured to the platform using surgical tape.
A silk suture was tied to the free end of the TA tendon and attached to the lever
arm of the apparatus (305C, Aurora Scientific), securing the TA muscle parallel to
the platform to measure force production. Two electrodes were placed against the
sciatic nerve for direct stimulation at 50 mA with 0.2 ms pulses, adjusting the lever
arm to achieve optimal length of the TA muscle allowing for maximal isometric
twitch force. Peak isometric tetanic force was measured by stimulating the sciatic
nerve at 50 mA with a frequency of 150 Hz for 350 ms. Force output was collected
by Dynamic Muscle Control (DMC v5.5) and analyzed by Dynamic Muscle
Analysis (DMA v5.3) (Aurora Scientific). After the force measurements, tibialis
anterior length and mass were measured to calculate physiological cross-sectional
area (PCA). PCA was calculated using the following formula [muscle mass (g) / 1.06
(fiber density) ×muscle length (cm) × 0.6 (muscle length to fiber length ratio)]53.
Specific force of individual muscles were determined by normalizing the maximal
isometric tetanic force (Po) to PCA. To evaluate fatigue resistance, repeated isometric
tetanic contractions were induced at 150 Hz every 10 s for a total of 50 contractions.
The loss of force generation after every 10 contractions was calculated and plotted as
a percentage of initial force.
Single myofiber force production. TA muscle samples, from 5 month-old mice,
were placed in relaxing solution at 4 °C and treated with skinning solution (relaxing
solution containing glycerol; 50:50 v/v) for 24 h at 4 °C. Bundles of ~50 myofibres
were then dissected and transferred to −20 °C54. On the day of experiment, single
myofibers were dissected from TA bundles in a relaxing solution. They were then
individually attached between connectors leading to a force transducer and a lever
arm system (model 1400 A; Aurora Scientific). Sarcomere length was set to ≈2.50
µm and the temperature to 15 °C. Fiber cross-sectional area (CSA) was estimated
from the width and depth, assuming an elliptical circumference. The absolute
maximal isometric force generation was calculated as the difference between the
total tension in the activating solution (pCa 4.50) and the resting tension measured
in the same myofiber while in the relaxing solution (pCa 9.0). Specific force was
defined as absolute force divided by CSA. Relaxing and activating solutions con-
tained 4 mMMg-ATP, 1 mM free Mg2+, 20 mM imidazole, 7 mM EGTA, 14.5 mM
creatine phosphate, and KCl to adjust the ionic strength to 180 mM and pH to 7.0.
The concentrations of free Ca2+ were 10−9.0 M (relaxing solution) and 10−4.5 M
(activating solution)54.
Inhibition of myostatin signaling. ACVR2B-Fc serves as a decoy receptor for
myostatin, which effectively inhibits myostatin/activin A signaling and induces
robust muscle hypertrophy, as previously described29,39. At 3.5 months of age, both
control and Δ2w mice were given ACVR2B-Fc by intraperitoneal injection at a
dose of 10 mg/kg. This dose was administered once a week for 4 weeks before tissue
was harvested for subsequent analysis.
RNA analysis. Flash-frozen muscle samples were weighed, and total RNA
extracted using standard Trizol-based protocols. Quality and concentrations of
RNA were determined using the Agilent 2100 Bioanalyzer [Gene Expression Core
(GEC) Facility (CCHMC)]. Microarray analysis for differential gene expression
(DGE) profiles was carried out at the GEC facility using the Affymetrix Clariom S
platform. Bioinformatics analyses of resultant data (CEL files) to determine DGE
between samples was carried out using the Transcriptome Analysis Console
(Applied Biosystems; ver. 4.0.0.25), the Clariom_S_Mouse TAC Configuration file
(ver. 2), and the iPathwayGuide (Advaita Bioinformatics). Gene Ontology
enrichment analysis for categorization by biological processes was achieved uti-
lizing the Panther Classification System55,56. Heat maps were generated from gene-
signals generated utilizing the Signal Space Transformation Robust Multi-Array
Average normalization method (sst-rma-gene-signals) for each gene of interest
using the Heatmapper software57. All original microarray data were deposited in
the NCBI’s Gene Expression Omnibus database (GSE141296).
mRNA contributions to total RNA content3 were calculated as a metric of
mRNA concentration (used as a measurement of adaptability in the genetic models
where myonuclear numbers were titrated) by normalizing sst-rma-gene signals for
every gene to total RNA amounts of the same sample. This value was then
normalized to EDL nuclei numbers to yield mRNA concentration on a per nuclear
basis. First-strand cDNA synthesis was carried out using the Superscript III Kit
(Invitrogen 18080400) using oligo dT primers. Semi-quantitative RT-PCR analysis
was performed on a C1000 Touch CFX96 real-time PCR machine (Bio-Rad) with
the following primers: Myh1: forward, 5′-CGGAGTCAGGTGAATACTCACG-3′;
reverse, 5′-GAGCATGAGCTAAGGCACTCT-3′, Myh4: forward, 5′-CTTTGCT
TACGTCAGTCAAGGT-3′; reverse, 5′-AGCGCCTGTGAGCTTGTAAA-3′,
Tnnc2: forward, 5′-GAGGCCAGGTCCTACCTCAG-3′; reverse, 5′-GGTGCCCAA
CTCTTTAACGCT-3′, Tnnt3: forward, 5′-GGAACGCCAGAACAGATTGG-3′;
reverse, 5′-TGGAGGACAGAGCCTTTTTCTT-3′, Acta1: forward, 5′-CCCAAAG
CTAACCGGGAGAAG-3′; reverse, 5′-CCAGAATCCAACACGATGCC-3′.
Results were normalized to glyceraldehyde phosphate dehydrogenase (GAPDH)
using the following primers: forward, 5′-TGCGACTTCAACAGCAACTC-3′;
reverse, 5′- GCCTCTCTTGCTCAGTGTCC-3′.
Measures of transcript abundance (used when not assessing myonuclear
flexibility) for Myh1, Myh4, Tnnc2, Tnnt3, and Acta1 were generated as a product
of expression levels determined by semi-quantitative RT-PCR as described above
for each sample and the total RNA amounts of the same sample. Transcript
abundance on a per nuclear basis was subsequently calculated by normalizing that
product to average myonuclear number (from the EDL).
Protein analysis. After recording of weights, flash-frozen muscle samples were
pulverized in a liquid nitrogen-cooled mortar and pestle, and then mechanically
homogenized on ice in known volumes of homogenization buffer [20 mM Tris (pH
7.3 with 1 N HCl), 1 mM EDTA, 1 mM dithiotreitol (DTT), 0.5% Triton X-100+
protease and phosphatase inhibitor cocktails (Sigma, P8340, P5726)]. Solubilization
was allowed to proceed on a nutator for 2 h at 4 °C, after which protein con-
centrations were measured using the Coomassie Plus (Bradford) Protein Assay Kit
(ThermoScientitic) against a BSA-based standard curve. Protein lysates were pre-
pared for SDS-PAGE analysis by heating at 95 °C for 10 min in 1× Laemmli sample
buffer containing 100 mM DTT. Proteins (2.5 μg/lane) were resolved on dis-
continuous polyacrylamide gels (7.5% for myosin heavy chains and 11.25% for
sarcomeric actin), and transferred to 0.2 μm nitrocellulose membranes (BioRad,
162-0112). Membranes blocked in 5% BSA were incubated with respective primary
antibodies diluted in 5% BSA [MF20 (1:20) deposited in DHSB58 against Myh
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isoforms, A2172 (1:1000; Sigma) against sarcomeric actin, and 10R-G109A
(1:10000; Fitzgerald) against GAPDH]. The resulting immunoblots generated after
incubation with relevant secondary antibodies [LiCOr Donkey anti-mouse IgG
against MF20 (926-68072), Goat anti-mouse IgM against A2172 (926-68080), and
Goat anti-mouse IgG against 10R-G109A (926-32210)] were scanned, imaged and
analyzed for densitometry using the Odyssey CLx imaging system (LI-COR
Biosciences, 9140).
Statistical analysis. Data were processed and analyzed using Microsoft Excel and
GraphPad Prism 8 software. Data sets are presented as mean ± SD, and data were
compared between groups using one-way ANOVA with a Tukey correction for
multiple comparisons, two-way ANOVA with a Tukey correction for multiple
comparisons, linear regression, or unpaired t-test. If unequal variances were
observed, a Welch’s t-test was used. Normality of data was also analyzed and if
non-normal, Mann–Whitney tests were used for comparison between two groups
or one-way ANOVA with a Kruskal–Wallis correction for multiple comparisons
was used. Specific statistical tests used are notated in individual figure legends.
Statistical significance was determined as p < 0.05.
Reporting Summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The datasets generated during the current study are available in the NCBI Gene
Expression Omnibus database (GSE141296), or are available from the corresponding
author upon reasonable request. Source data are provided with this paper.
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